Ividata

Ividata is a company that has been supporting the life sciences sector since 2013, offering a comprehensive range of services including biostatistics, programming, data management, clinical operations, medical writing, vigilance, regulatory affairs, quality assurance, and engineering. The company serves clients in the pharmaceutical, biotechnology, medical devices, cosmetics, and nutrition industries. Ividata has completed over 250 projects in 2021 and employs over 200 collaborators in France and Belgium, with offices in Levallois-Perret, Paris, and Lyon. The company provides solutions through projects & forfaits, consulting, and personalized service centers, supporting clients in all phases of development from early stages to post-marketing authorization (AMM). Ividata conducts various studies such as ‘First in Man’, PK/PD studies, biomarker studies, genome-wide association studies (GWAS), proof of concept (POC) studies, and dose-finding studies. It also handles regulatory affairs for pharmaceuticals, medical devices, and cosmetics, ensuring compliance with MDR 2017/745 and ISO 13485. The company has achieved a doubled turnover within three years and maintains annual double-digit growth. Ividata is certified for HDS hosting and QMS, and it engages in partnerships with French and international associations for financial and logistical support. The company organizes 10 scientific webinars per year and has six professional communities led by a technical direction. Ividata focuses on human-centric values, striving for excellence, and continuous innovation.